Pharmaceutical care on a patient with lung adenocarcinoma, left lung obstructive pneumonia and left lower extremity deep vein thrombosis

Chun-yan QIAN,Hui-zhu SONG,Xiao-jun CAI

DOI: https://doi.org/10.3969/j.issn.1672-8157.2016.06.007

2016-01-01

Abstract:One case of middle-aged female patient was admitted to hospital due to left lung adenocarcinoma. Her admitting diagnosis were left lung adenocarcinoma, left lung obstructive pneumonia, left lower extremity deep vein thrombosis. Low molecular weight heparin and warfarin were successively given to the patient for lower limb venous thrombus. Clinical pharmacist evaluated the rationality of the overlapping time of the low molecular weight heparin and warfarin, and adjusted the dosage of warfarin according to INR values. Megestrol acetate dispersible tablets was withdrawn because it might contribute to the formation of deep vein thrombosis. Clinical pharmacists analyzed that developed and aggravated thrombosis might be resulted in the combining use of antibiotics, chemotherapeutic agents and warfarin, which was forwarded to doctors. Discharge education was offered to the patient, such as avoiding taking drugs and foods which can affect the blood concentration of warfarin, monitoring INR values and so on.